Fractyl Health (GUTS) Assets (2023 - 2026)
Fractyl Health (GUTS) reported Assets of $99.4 million for Q1 2026, up 19.68% year-on-year from $83.0 million in Q1 2025, and down 18.14% quarter-over-quarter from $121.4 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Assets data on file, last reported at $99.4 million in Q1 2026.
- For the quarter ending Q1 2026, Assets rose 19.68% year-over-year to $99.4 million; the trailing twelve-month figure through Mar 2026 stood at $99.4 million (up 19.68% YoY), and the FY2025 full-year result was $121.4 million, up 12.33% from the prior year.
- Assets for Q1 2026 stood at $99.4 million, down from $121.4 million in the prior quarter.
- Across five years, Assets topped out at $163.5 million in Q1 2024 and bottomed at $62.0 million in Q2 2025.
- A 4-year average of $110.1 million and a median of $111.2 million in 2024 frame the typical range for Assets.
- Across the five-year window, Assets surged 41.81% in 2024 and tumbled 57.66% in 2025, its largest moves.
- Tracing GUTS's Assets over 4 years: stood at $76.2 million in 2023, then surged by 41.81% to $108.1 million in 2024, then gained by 12.33% to $121.4 million in 2025, then decreased by 18.14% to $99.4 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $99.4 million, $121.4 million, and $114.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 40.87 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 23.64 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 99.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.39 Mn |
| Dec 31, 2025 | 121.40 Mn |
| Sep 30, 2025 | 114.27 Mn |
| Jun 30, 2025 | 62.01 Mn |
| Mar 31, 2025 | 83.04 Mn |
| Dec 31, 2024 | 108.08 Mn |
| Sep 30, 2024 | 126.92 Mn |
| Jun 30, 2024 | 146.44 Mn |
| Mar 31, 2024 | 163.52 Mn |
| Dec 31, 2023 | 76.21 Mn |